First mRNA cancer vaccine shows efficacy in skin cancer trial

A personalized mRNA vaccine for melanoma demonstrated efficacy in a clinical trial, marking the first successful use of this technology against cancer. The treatment, developed with AI-assisted design, reduced recurrence risk, though full data and regulatory approval remain pending. This validates the mRNA platform beyond infectious disease and could reshape oncology treatment paradigms.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works